Obermatt
See Similar Stocks →

Flags

Financial distress

DarioHealth

NAQ:DRIO · US23725P3082
Health Care TechnologySmall

360

20
Profit price66
Owner Earnings Yield1
Dividend Yield1
Price/Sales63
EV / Gross Profit27
Price/Book72
Return on Capital23
Cash Return on Capital20
Return on Equity23
EBIT Margin1
Gross Profitability12
Accruals72
Owner Earnings Margin11
Sales growth81
Profit growth16
Reinvestment38
Price momentum26
Debt load29
Refinancing23
Debt Payback1
Liquidity22
Analyst ratings76
Opinion Changes50
Price Target Upside77
Market mood4
Value Creation2/20not creating value
  • Creates more value than its capital costs
  • Owner earnings growing
  • Owner earnings per share growing
  • Reinvests at strong returns
  • Solid earnings base

What this means

DarioHealth doesn't consistently earn more than its cost of capital, so it isn't yet creating shareholder value.

Profile

CountryUSA
IndustryHealth Care Technology
SizeSmall
TypePublic Company
ExchangeNASDAQCM
Founded2011
Employees215
Websiteshop.mydario.com
ISINUS23725P3082
Last UpdateApr 2, 2026
Indices
NASDAQ (USA)
Themes
MHealthCardiovascularPain ManagementCorporate Wellness ProgramsFitness TechnologyDiabetesDigital Mental HealthArtificial IntelligenceDigital WellnessChronic DiseasesWellness and RecoveryPredictive AnalyticsHealth CareHealth DiagnosticsMedical DeviceSoftwareTherapeutics

Description

DarioHealth Corp. operates as a global digital therapeutics (DTx) company. The company delivers personalized evidence-based interventions that are driven by precision data analytics, software, and personalized coaching. It has developed an approach…

Analysis

Weak and unloved

DarioHealth Corp. scores below average on quality and is priced accordingly, a low-conviction position in either direction.

Valuation data is not available for this company.

Growth is solid; the safety picture is stretched. The company scores 2/20 on our value-creation score: not creating value.

Flags to be aware of: A large part of the company's book value is the price paid for past acquisitions. Some accounting patterns deserve a closer look. As always: this describes the company's numbers; it is not a recommendation.

360° rank · history

1007550250
11
2023202420252026

All-time high

61

Jan 2023

All-time low

11

Jun 2026

Average rank

30

across all years

Detailed & Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history.

Current202520242023
Price/Sales
63
91
58
32
Price/Earnings
83
34
34
34
Price/Book
72
97
88
84
Dividend Yield
1
1
1
1
Value (overall)
70
76
53
47

Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.

Similar Stocks

The companies this stock is ranked against.

Compare DarioHealth with its peers
OptimizeRx
NAQ:OPRX
82
CountryUSA
IndustryHealth Care Technology
SizeSmall
Full Stock Analysis →
Badger Meter
NYQ:BMI
50
CountryUSA
IndustryElectronic Equipment, Instruments & Components
SizeMedium
Full Stock Analysis →
Cohu
NSQ:COHU
30
CountryUSA
IndustrySemiconductors & Semiconductor Equipment
SizeMedium
Full Stock Analysis →
Vontier
NYQ:VNT
50
CountryUSA
IndustryElectronic Equipment, Instruments & Components
SizeLarge
Full Stock Analysis →
Forian
NAQ:FORA
23
CountryUSA
IndustryHealth Care Technology
SizeSmall
Full Stock Analysis →
electroCore
NAQ:ECOR
44
CountryUSA
IndustryHealth Care Equipment & Supplies
SizeSmall
Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100
Learn More →